We are live on
!
Find out more
IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
1-Year Est. Return
10.79%
This Fund
S&P 500
This Quarter
Est. Return
+11.92%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
–
Cap. Flow
+$179M
Cap. Flow
% of AUM
90.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yext
YEXT
|
+$64.3M |
| 2 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$45.5M |
| 3 |
NovoCure
NVCR
|
+$38M |
| 4 |
Arcus Biosciences
RCUS
|
+$15.5M |
| 5 |
UBX
Unity Biotechnology
UBX
|
+$15.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.67% |
| 2 | Technology | 30.33% |
Similar funds
ETIA
CC
OAMA
FWM
GIM
YSP
EL
CH
Invus Financial Advisors's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Invus Financial Advisors, which disclosed 5 positions worth $197M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Yext: 4,146,784 shares worth $59.8M.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, followed by Technology.
- Invus Financial Advisors's largest Q4 2019 buy was Yext: 4,146,784 shares worth $59.8M.
- Invus Financial Advisors's ten largest holdings make up 100% of its $197M portfolio in Q4 2019.
- Invus Financial Advisors disclosed 5 positions in Q4 2019, its first 13F filing on record.
Based on Invus Financial Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.